Skip to content
Lower risk Medical device recall · FDA · Published September 11, 2020

Fujifilm Synapse PACS Software 5.6.1: Possible 3D Sphere MAX Value Errors

Fujifilm recalls Synapse PACS Software Version 5.6.1 due to potential over-reporting of 3D Sphere MAX values in CT studies. Affected users should contact Fujifilm for guidance.

🇺🇸 FDA recall #Z-0282-2021Medical deviceFujifilm ›
Take action

Contact the company

Recalling firmFujifilm Medical Systems U.S.A., Inc.81 Hartwell Ave Ste 300 · Lexington, MA 02421-3160
✎ GovInfoNow plain-language explainer

Fujifilm is recalling Synapse PACS Software Version 5.6.1 because it may report higher-than-expected 3D Sphere MAX values in CT studies. This could lead to incorrect medical interpretations if not addressed. Read more at govinfonow.com/recall/64306-fujifilm-synapse-pacs-software-5-6-1-possible-3d-sphere.

Source Summary by GovInfoNow · govinfonow.com/recall/64306-fujifilm-synapse-pacs-software-5-6-1-possible-3d-sphere · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0282-2021

Cite this page

“Fujifilm Synapse PACS Software 5.6.1: Possible 3D Sphere MAX Value Errors.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64306-fujifilm-synapse-pacs-software-5-6-1-possible-3d-sphere. Based on FDA recall #Z-0282-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0282-2021%22&limit=1).

The FDA announced on Sept. 11, 2020, that Fujifilm Medical Systems U.S.A., Inc. is recalling Synapse PACS Software Version 5.6.1 due to the possibility of CT studies reporting erroneously high 3D Sphere MAX values.

How to tell if you have it

  • Brand: Fujifilm
  • Product: Synapse PACS Software Version 5.6.1
  • Distribution: US Nationwide, including Minnesota

The hazard

Fujifilm has identified that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to the 3D Sphere tool; other density tools are not affected.

Context

GovInfoNow's records show Fujifilm Medical Systems U.S.A., Inc. has had 13 other recalls on record since June 15, 2017. Other recent recalls of similar products include Fujifilm Synapse CV Software 6.0-6.2.1 (April 30, 2021), Fujifilm Synapse PACS (March 2, 2021), and Fujifilm Wako TASWako i30 Chip Cassette (Feb. 18, 2021). Other recent recalls of similar products include FUJIFILM Synapse PACS Software v7.4.310 (July 22, 2026).

How to tell if you have this one

Check if you have Fujifilm Synapse PACS Software Version 5.6.1 installed on an off-the-shelf PC used for medical imaging. The software is intended for web-based use with a Fujifilm Synapse PACS server.

  • Brand
    Fujifilm
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Contact Fujifilm

    Reach out to Fujifilm Medical Systems U.S.A., Inc. for guidance on potential issues with the software version.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution including in the state of Minnesota.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Sep 11, 202012. FDA classified it Class II: Oct 22, 202023. Published in FDA’s Enforcement Report: Oct 28, 202034. FDA terminated the recall: Nov 17, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0282-2021 (September 11, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0282-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA